Angiotensin II type 2-receptor agonist C21 reduces proteinuria and oxidative stress in kidney of high-salt-fed obese zucker rats

Hypertension

Volumn 67, Issue 5, 2016, Pages 906-915

  Patel, Sanket N ^a   Ali, Quaisar ^a   Hussain, Tahir ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

AT2 receptor; NADPH oxidase; oxidative stress; rats, Zucker

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTANE; ANGIOTENSIN 2 RECEPTOR; C 21; CREATININE; CUBILIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HORMONE RECEPTOR AFFECTING AGENT; HYDROGEN PEROXIDE; MEGALIN; N ACETYL BETA GLUCOSAMINIDASE; NITROGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG; UREA; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; SALT INTAKE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; FIBROSING ALVEOLITIS; FRACTIONAL EXCRETION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HIGH SODIUM INTAKE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY INJURY; KIDNEY STRUCTURE; MALE; NITROSATIVE STRESS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION; ZUCKER RAT; ACUTE KIDNEY INJURY; ANALYSIS OF VARIANCE; ANIMAL; BLOOD PRESSURE; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; METABOLISM; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; PHARMACOLOGY; RANDOMIZATION; REFERENCE VALUE; SALT INTAKE;

ACUTE KIDNEY INJURY; ANALYSIS OF VARIANCE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIOPSY, NEEDLE; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PROTEINURIA; RANDOM ALLOCATION; RATS; RATS, ZUCKER; REFERENCE VALUES; SODIUM CHLORIDE, DIETARY;

EID: 84961970471     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06881     Document Type: Article

References (67)

1. Hall JE, Guyton AC, Brands MW, Pressure-volume regulation in hypertension. Kidney Int Suppl 1996 55 S35 S41
2. Reisin E, Sodium and obesity in the pathogenesis of hypertension. Am J Hypertens 1990 3 164 167
3. Rahmouni K, Correia ML, Haynes WG, Mark AL, Obesity-Associated hypertension: new insights into mechanisms. Hypertension 2005 45 9 14. doi: 10.1161/01.HYP.0000151325.83008.b4
4. Wu MT, Lam KK, Lee WC, Hsu KT, Wu CH, Cheng BC, Ng HY, Chi PJ, Lee YT, Lee CT, Albuminuria, proteinuria, and urinary albumin to protein ratio in chronic kidney disease. J Clin Lab Anal 2012 26 82 92. doi: 10.1002/jcla.21487
5. Ali Q, Patel S, Hussain T, Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats. Am J Physiol Renal Physiol 2015 308 F1379 F1385. doi: 10.1152/ajprenal.00002.2015
6. Teschner M, Paczek L, Schaefer RM, Heidland A, Obese Zucker rat: potential role of intraglomerular proteolytic enzymes in the development of glomerulosclerosis. Res Exp Med (Berl) 1991 191 129 135
7. Samuel P, Ali Q, Sabuhi R, Wu Y, Hussain T, High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats. Am J Physiol Renal Physiol 2012 303 F412 F419. doi: 10.1152/ajprenal.00097.2012
8. Lavaud S, Michel O, Sassy-Prigent C, Heudes D, Bazin R, Bariéty J, Chevalier J, Early influx of glomerular macrophages precedes glomerulosclerosis in the obese Zucker rat model. J Am Soc Nephrol 1996 7 2604 2615
9. Wolf G, Novel aspects of the renin-Angiotensin-Aldosterone-system. Front Biosci 2008 13 4993 5005
10. Wolf G, Ziyadeh FN, The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 1997 29 153 163
11. Poirier B, Lannaud-Bournoville M, Conti M, Bazin R, Michel O, Bariéty J, Chevalier J, Myara I, Oxidative stress occurs in absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats. Nephrol Dial Transplant 2000 15 467 476
12. Reckelhoff JF, Romero JC, Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol Regul Integr Comp Physiol 2003 284 R893 R912. doi: 10.1152/ajpregu.00491.2002
13. Mori T, Cowley AW Jr., Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-Talk in renal outer medulla. Hypertension 2003 42 588 593. doi: 10.1161/01.HYP.0000091821.39824.09
14. Ohisa N, Yoshida K, Matsuki R, Suzuki H, Miura H, Ohisa Y, Murayama N, Kaku M, Sato H, A comparison of urinary albumin-Total protein ratio to phase-contrast microscopic examination of urine sediment for differentiating glomerular and nonglomerular bleeding. Am J Kidney Dis 2008 52 235 241. doi: 10.1053/j.ajkd.2008.04.014
15. Park EY, Kim TY, Fractional excretion of protein may be a useful predictor of decline of renal function in pan-chronic kidney diseases. Nephrol Dial Transplant 2011 26 1746 1747. doi: 10.1093/ndt/gfr090
16. McQuarrie EP, Shakerdi L, Jardine AG, Fox JG, Mackinnon B, Fractional excretions of albumin and IgG are the best predictors of progression in primary glomerulonephritis. Nephrol Dial Transplant 2011 26 1563 1569. doi: 10.1093/ndt/gfq605
17. Birmingham DJ, Rovin BH, Shidham G, Bissell M, Nagaraja HN, Hebert LA, Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications. Clin J Am Soc Nephrol 2008 3 1028 1033. doi: 10.2215/CJN.04761107
18. Samarawickrama A, Cai M, Smith ER, Nambiar K, Sabin C, Fisher M, Gilleece Y, Holt SG, Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria. HIV Med 2012 13 526 532. doi: 10.1111/j.1468-1293.2012.01003.x
19. Smith ER, Cai MM, McMahon LP, Wright DA, Holt SG, The value of simultaneous measurements of urinary albumin and total protein in proteinuric patients. Nephrol Dial Transplant 2012 27 1534 1541. doi: 10.1093/ndt/gfr708
20. Hakam AC, Hussain T, Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats. Hypertension 2005 45 270 275. doi: 10.1161/01.HYP.0000151622.47814.6f
21. Hakam AC, Siddiqui AH, Hussain T, Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol 2006 290 F503 F508. doi: 10.1152/ajprenal.00092.2005
22. Namsolleck P, Recarti C, Foulquier S, Steckelings UM, Unger T, AT(2) receptor and tissue injury: therapeutic implications. Curr Hypertens Rep 2014 16 416. doi: 10.1007/s11906-013-0416-6
23. Dhande I, Ma W, Hussain T, Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-Activated THP-1 macrophages via increased interleukin-10 production. Hypertens Res 2015 38 21 29. doi: 10.1038/hr.2014.132
24. Rehman A, Leibowitz A, Yamamoto N, Rautureau Y, Paradis P, Schiffrin EL, Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 2012 59 291 299. doi: 10.1161/HYPERTENSIONAHA.111.180158
25. Nasser M, Clere N, Botelle L, Javellaud J, Oudart N, Faure S, Achard JM, Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice. Cardiovasc Diabetol 2014 13 40. doi: 10.1186/1475-2840-13-40
26. Sohn HY, Raff U, Hoffmann A, Gloe T, Heermeier K, Galle J, Pohl U, Differential role of angiotensin II receptor subtypes on endothelial superoxide formation. Br J Pharmacol 2000 131 667 672. doi: 10.1038/sj.bjp.0703566
27. Wang G, Coleman CG, Glass MJ, Zhou P, Yu Q, Park L, Anrather J, Pickel VM, Iadecola C, Angiotensin II type 2 receptor-coupled nitric oxide production modulates free radical availability and voltage-gated Ca2+ currents in NTS neurons. Am J Physiol Regul Integr Comp Physiol 2012 302 R1076 R1083. doi: 10.1152/ajpregu.00571.2011
28. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS, Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 2003 285 R117 R124. doi: 10.1152/ajpregu.00476.2002
29. Lu J, Wu L, Jiang T, Wang Y, Zhao H, Gao Q, Pan Y, Tian Y, Zhang Y, Angiotensin AT2 receptor stimulation inhibits activation of NADPH oxidase and ameliorates oxidative stress in rotenone model of Parkinson's disease in CATH.a cells. Neurotoxicol Teratol 2015 47 16 24. doi: 10.1016/j.ntt.2014.11.004
30. Min LJ, Mogi M, Tsukuda K, Jing F, Ohshima K, Nakaoka H, Kan-No H, Wang XL, Chisaka T, Bai HY, Iwanami J, Horiuchi M, Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage. Am J Hypertens 2014 27 1036 1044. doi: 10.1093/ajh/hpu015
31. Coimbra TM, Janssen U, Gröne HJ, Ostendorf T, Kunter U, Schmidt H, Brabant G, Floege J, Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000 57 167 182. doi: 10.1046/j.1523-1755.2000.00836.x
32. Johns EJ, O'Shaughnessy B, O'Neill S, Lane B, Healy V, Impact of elevated dietary sodium intake on NAD(P)H oxidase and SOD in the cortex and medulla of the rat kidney. Am J Physiol Regul Integr Comp Physiol 2010 299 R234 R240. doi: 10.1152/ajpregu.00541.2009
33. Liang M, Berndt TJ, Knox FG, Mechanism underlying diuretic effect of L-NAME at a subpressor dose. Am J Physiol Renal Physiol 2001 281 F414 F419
34. Ortiz PA, Garvin JL, Interaction of O(2)(-) and NO in the thick ascending limb. Hypertension 2002 39 2 pt 2 591 596
35. Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD Jr., Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 2003 41 1346 1352. doi: 10.1161/01.HYP.0000070028.99408.E8
36. Koulis C, Chow BS, McKelvey M, Steckelings UM, Unger T, Thallas-Bonke V, Thomas MC, Cooper ME, Jandeleit-Dahm KA, Allen TJ, AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathy. Hypertension 2015 65 1073 1081. doi: 10.1161/HYPERTENSIONAHA.115.05204
37. Shao C, Yu L, Gao L, Activation of angiotensin type 2 receptors partially ameliorates streptozotocin-induced diabetes in male rats by islet protection. Endocrinology 2014 155 793 804. doi: 10.1210/en.2013-1601
38. Lombardi D, Gordon KL, Polinsky P, Suga S, Schwartz SM, Johnson RJ, Salt-sensitive hypertension develops after short-Term exposure to Angiotensin II. Hypertension 1999 33 1013 1019
39. Vaziri ND, Bai Y, Ni Z, Quiroz Y, Pandian R, Rodriguez-Iturbe B, Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther 2007 323 85 93. doi: 10.1124/jpet.107.123638
40. Seifi B, Kadkhodaee M, Karimian SM, Zahmatkesh M, Xu J, Soleimani M, Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage. Clin Exp Hypertens 2010 32 90 97. doi: 10.3109/10641960902993111
41. Li Z, Rodríguez-Iturbe B, Ni Z, Shahkarami A, Sepassi L, Vaziri ND, Effect of hereditary obesity on renal expressions of NO synthase, caveolin-1, AKt, guanylate cyclase, and calmodulin. Kidney Int 2005 68 2766 2772. doi: 10.1111/j.1523-1755.2005.00747.x
42. Alvarez V, Quiroz Y, Nava M, Pons H, Rodríguez-Iturbe B, Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 2002 283 F1132 F1141. doi: 10.1152/ajprenal.00199.2002
43. Dhande I, Ali Q, Hussain T, Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats. Hypertension 2013 61 1218 1226. doi: 10.1161/HYPERTENSIONAHA.111.00422
44. Raij L, Azar S, Keane W, Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984 26 137 143
45. Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T, Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension 2007 50 877 883. doi: 10.1161/HYPERTENSIONAHA.107.091058
46. Fujii S, Zhang L, Kosaka H, Albuminuria, expression of nicotinamide adenine dinucleotide phosphate oxidase and monocyte chemoattractant protein-1 in the renal tubules of hypertensive Dahl salt-sensitive rats. Hypertens Res 2007 30 991 998. doi: 10.1291/hypres.30.991
47. Matsubara H, Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998 83 1182 1191
48. Wu L, Iwai M, Li Z, Shiuchi T, Min LJ, Cui TX, Li JM, Okumura M, Nahmias C, Horiuchi M, Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-Activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells. Mol Endocrinol 2004 18 666 678. doi: 10.1210/me.2003-0053
49. Kaschina E, Grzesiak A, Li J, Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-Angiotensin system in myocardial infarction? Circulation 2008 118 2523 2532. doi: 10.1161/CIRCULATIONAHA.108.784868
50. Gelosa P, Pignieri A, Fändriks L, de Gasparo M, Hallberg A, Banfi C, Castiglioni L, Turolo L, Guerrini U, Tremoli E, Sironi L, Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage. J Hypertens 2009 27 2444 2451. doi: 10.1097/HJH.0b013e3283311ba1
51. Rompe F, Artuc M, Hallberg A, Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension 2010 55 924 931. doi: 10.1161/HYPERTENSIONAHA.109.147843
52. Matavelli LC, Huang J, Siragy HM, Angiotensin AT2 receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 2011 57 308 313. doi: 10.1161/HYPERTENSIONAHA.110.164202
53. Kania K, Byrnes EA, Beilby JP, Webb SA, Strong KJ, Urinary proteases degrade albumin: implications for measurement of albuminuria in stored samples. Ann Clin Biochem 2010 47 pt 2 151 157. doi: 10.1258/acb.2009.009247
54. Burne MJ, Osicka TM, Comper WD, Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Kidney Int 1999 55 261 270
55. Burne MJ, Panagiotopoulos S, Jerums G, Comper WD, Alterations in renal degradation of albumin in early experimental diabetes in the rat: a new factor in the mechanism of albuminuria. Clin Sci (Lond) 1998 95 67 72
56. Dickson LE, Wagner MC, Sandoval RM, Molitoris BA, The proximal tubule and albuminuria: really! J Am Soc Nephrol 2014 25 443 453. doi: 10.1681/ASN.2013090950
57. Fioretto P, Stehouwer CD, Mauer M, Chiesura-Corona M, Brocco E, Carraro A, Bortoloso E, van Hinsbergh VW, Crepaldi G, Nosadini R, Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia 1998 41 233 236. doi: 10.1007/s001250050895
58. Arkin A, Popper H, Urea reabsorption and relation between creatinine and urea clearance in renal disease. Arch Intern Med 1940 65 627 637
59. Perrone RD, Madias NE, Levey AS, Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992 38 1933 1953
60. Bankir L, Ahloulay M, Bouby N, Trinh-Trang-Tan MM, Machet F, Lacour B, Jungers P, Is the process of urinary urea concentration responsible for a high glomerular filtration rate? J Am Soc Nephrol 1993 4 1091 1103
61. Morgan DB, Carver ME, Payne RB, Plasma creatinine and urea: creatinine ratio in patients with raised plasma urea. Br Med J 1977 2 929 932
62. Carvounis CP, Nisar S, Guro-Razuman S, Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 2002 62 2223 2229. doi: 10.1046/j.1523-1755.2002.00683.x
63. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 8 R204 R212. doi: 10.1186/cc2872
64. O'Donnell MP, Kasiske BL, Katz SA, Schmitz PG, Keane WF, Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats. Hypertension 1992 20 651 658
65. Laverman GD, Van Goor H, Henning RH, De Jong PE, De Zeeuw D, Navis G, Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes. Kidney Int 2003 63 64 71. doi: 10.1046/j.1523-1755.2003.00708.x
66. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE trial group Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004 363 2022 2031. doi: 10.1016/S0140-6736(04)16451-9
67. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A, SCOPE Study Group The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003 21 875 886. doi: 10.1097/01.hjh.0000059028.82022.89